We are live on ! Find out more
ZYME icon

Zymeworks

116 hedge funds and large institutions have $1.17B invested in Zymeworks in 2020 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 35 increasing their positions, 31 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

71% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 21

13% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 31

13% more funds holding

Funds holding: 103116 (+13)

12.24% more ownership

Funds ownership: 60.4%72.64% (+12%)

9% more capital invested

Capital invested by funds: $1.08B → $1.17B (+$93.5M)

37% less call options, than puts

Call options by funds: $5.17M | Put options by funds: $8.16M

Holders
116
Holders Change
+13
Holders Change %
+12.62%
% of All Funds
2.56%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
36
Increased
35
Reduced
31
Closed
21
Calls
$5.17M
Puts
$8.16M
Net Calls
-$2.99M
Net Calls Change
+$309K
Name Holding Trade Value Shares
Change
Change in
Stake
PA
1
Perceptive Advisors
New York
$126M +$47.4M +1,157,973 +48%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$121M +$18.8M +460,524 +16%
Fidelity International
3
Fidelity International
Bermuda
$114M +$65.8M +1,608,522 +99%
GPP
4
Great Point Partners
Connecticut
$82.5M +$4.13M +100,899 +5%
FCM
5
Farallon Capital Management
California
$62.1M +$2.05M +50,000 +3%
BBA
6
Baker Bros. Advisors
New York
$60.6M
VC
7
Vivo Capital
California
$39.1M +$45.1M +1,101,236 New
PC
8
Polar Capital
United Kingdom
$34.2M +$1.24M +30,196 +3%
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$34.1M +$3.51M +85,843 +10%
CS
10
Credit Suisse
Switzerland
$32.1M +$33.3M +814,101 +896%
RG
11
Redmile Group
California
$30.8M +$35.5M +868,600 New
Point72 Asset Management
12
Point72 Asset Management
Connecticut
$29.5M +$34M +830,507 New
Renaissance Technologies
13
Renaissance Technologies
New York
$28.4M +$11M +268,152 +50%
CAM
14
Cormorant Asset Management
Massachusetts
$24.8M
O
15
OrbiMed
New York
$20.7M +$23.8M +582,302 New
Victory Capital Management
16
Victory Capital Management
Texas
$17.8M +$9.87M +241,241 +93%
Franklin Resources
17
Franklin Resources
California
$17.4M -$3.89M -95,100 -16%
Two Sigma Advisers
18
Two Sigma Advisers
New York
$16.8M +$7.68M +187,700 +66%
WP
19
Woodline Partners
California
$15.8M +$7.01M +171,216 +63%
Citadel Advisors
20
Citadel Advisors
Florida
$15.1M +$3.94M +96,348 +29%
HM
21
HealthCor Management
New York
$14.8M +$17.1M +416,700 New
BNP Paribas Asset Management
22
BNP Paribas Asset Management
France
$14.1M +$3.82M +93,244 +31%
PAMU
23
Pictet Asset Management (UK)
United Kingdom
$11.8M -$655K -16,005 -5%
Lord, Abbett & Co
24
Lord, Abbett & Co
New Jersey
$11.3M +$13.1M +319,695 New
LGM
25
Logos Global Management
California
$10.8M -$3.47M -84,736 -22%

ZYME Hedge Fund Activity: Q1 2020 in Review

116 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q1 2020, worth a combined $1.17B — up 8.6% from $1.08B a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new ZYME positions and 21 closed out — a net gain of 15 holders — while 35 added to existing stakes and 31 trimmed.

The largest buyer was Fidelity International, adding an estimated $65.8M. The largest seller was Samlyn Capital, exiting entirely with an estimated $14.4M sold.

  • 116 institutional investors held Zymeworks (ZYME) as of Q1 2020, up from 103 in Q4 2019.
  • Funds reported $1.17B of Zymeworks stock for Q1 2020, up 8.6% quarter-over-quarter.
  • 36 funds opened new Zymeworks positions in Q1 2020 and 21 closed out, a net change of +15 holders.
  • The largest Zymeworks buyer in Q1 2020 was Fidelity International, an estimated $65.8M added.
  • The largest Zymeworks seller in Q1 2020 was Samlyn Capital, an estimated $14.4M sold.

Based on aggregated 13F filings for Q1 2020.